Lotus Eye Hospital and Institute

What Lotus Eye Hospital and Institute does

Lotus Eye Hospital and Institute Limited is a publicly listed (NSE: LOTUSEYE) super-specialty ophthalmology hospital chain headquartered in Coimbatore, Tamil Nadu, founded in 1990 by Dr. S.K. Sundaramoorthy. The company operates 10 state-of-the-art eye care centers across Tamil Nadu and Kerala (8 in Tamil Nadu and 2 in Kerala), supported by 500+ qualified staff and an in-house team of ophthalmologists performing approximately 400+ outpatient consultations daily at the flagship Sitra center. Lotus has cumulatively served 8 million+ patients and performed 35,000+ LASIK procedures, with service lines spanning refractive surgery (LASIK, ReLEx SMILE, AI-enabled SMILE PRO, SCHWIND AMARIS touch-free laser, Epi-LASIK, Intralase, Zyoptix Ultimate/Supracor), cataract surgery (Robotic Femto LRCS, Phaco, MICS), cornea and ocular surface, retinal/vitreo-retinal care, glaucoma, pediatric ophthalmology, binocular vision therapy, orbit and oculoplasty, and ocular prosthesis. Technology stack is built on premium imported platforms — Carl Zeiss VisuMax (SMILE PRO), SCHWIND AMARIS 750S, Technolas 217P, and Alcon LenSx — licensed from leading German and US ophthalmic equipment OEMs.

The business model combines direct-to-consumer healthcare delivery with insurance/TPA cashless billing, government scheme coverage, educational revenue, and ancillary services. Patient revenue is generated per-procedure with prices ranging from Rs. 9,999 (discounted LASIK) to Rs. 1,25,000 (ReLEx SMILE) per eye, supplemented by optical retail, in-house pharmacy (~80% of prescriptions), and an eye bank. Distribution is via the 10 hospital centers plus eye camps, school screenings, and rural outreach through Lotus Vision Research Trust, with international patient services targeting medical tourists from the USA, UK, Middle East, Australia, Singapore, Sri Lanka, Bangladesh, Nepal, and Africa. Academic revenue comes from a B.Sc. Optometry program affiliated with Alagappa University, a 10-seat DNB ophthalmology program, and paid fellowships in cornea/refractive, vitreo-retinal, glaucoma, and comprehensive ophthalmology (Rs. 40,000-50,000/month stipends). The company generates cashless patient flow through 20+ TPAs and 20+ insurance company partnerships plus government schemes (CM Scheme, ESI, PMJAY, RSBY). Operationally, Lotus is a mature, vertically integrated regional eye hospital chain whose competitive positioning rests on multi-decade brand, premium imported equipment, academic training pipeline, and integrated insurance/government billing rails.

Name

Lotus Eye Hospital and Institute

Legal name

Lotus Eye Hospital and Institute Limited

Website

https://lotuseye.org

Company type

Public

Founded year

1990

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Lotus Eye Hospital and Institute is a publicly listed super-specialty eye hospital chain operating 10 centers across Tamil Nadu and Kerala, offering refractive surgery, cataract, retinal, and pediatric ophthalmology services to over 8 million lifetime patients with premium imported laser technology.

Ownership category

akta.pro rank

Product category

Ophthalmology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Optometrists (62132)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ophthalmic Specialty Hospitals (HLAFAHAJ)

akta.pro secondary industries

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC), Comprehensive Eye Exams & Vision Care (HLAKAKAA), Retina & Vitreous Specialists (HLAKAKAE), Optometry Clinics (Primary Eye Care) (HLAKAKAB)

Keywords

• Ophthalmology services
• Refractive eye surgery
• Cataract treatment
• Retinal eye care
• LASIK vision correction

Headquarters

HQ city

Coimbatore

HQ country

India

HQ region

Asia

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Patient Healthcare Services: Direct revenue from patient consultations, diagnostic services, and surgical procedures across all 10 hospital centers. Services include refractive surgery (LASIK, SMILE, SMILE PRO), cataract surgery, retinal treatments, pediatric eye care, glaucoma treatment, and corneal procedures.
2. Optical Products and Lenses: Revenue from optical outlets at hospital locations selling spectacles, lenses (single vision, bi-focal, multifocal, progressive), and contact lenses.
3. Pharmacy Services: In-house pharmacy providing medications to inpatients and outpatients, serving approximately 80% of patients who receive prescriptions.
4. Insurance and TPA Revenue: Revenue from partnerships with multiple Third Party Administrators and insurance companies including United India Insurance, Apollo Munich, HDFC ERGO, ICICI Lombard, and government schemes like CM Scheme and ESI.
5. Academic and Training Programs: Revenue from educational programs including B.Sc. Optometry (registered with Alagappa University), DNB ophthalmology (10 seats), and various fellowship programs in cornea, retina, glaucoma, and refractive surgery.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels10 records

Core offering

Lotus Eye Hospital and Institute operates a multi-center network of 10 super specialty eye care hospitals across Tamil Nadu and Kerala, delivering comprehensive ophthalmology services including advanced laser vision correction (SMILE PRO, ReLEx SMILE, LASIK variants, Touchfree Laser), cataract surgery (LRCS, Phaco, MICS), retinal treatments, glaucoma management, pediatric ophthalmology, corneal transplants, and binocular vision therapy. The hospital supports its clinical services with in-house optical retail, pharmacy, an eye bank, academic training programs (B.Sc. Optometry, DNB, fellowships), and charitable outreach through Lotus Vision Research Trust.

Product overview

Lotus Eye Hospital and Institute is a multi-center super specialty eye hospital network offering a comprehensive ophthalmology portfolio across 10 locations in Tamil Nadu and Kerala. The core product portfolio centers on advanced laser vision correction technologies including SMILE PRO (AI-enabled), ReLEx SMILE (bladeless/flapless), Touchfree Laser (SCHWIND AMARIS), LASIK variants (Standard, Zyoptix, Zyoptix Ultimate), Epi-LASIK, and Intralase for blade-free procedures. Surgical offerings include Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, and Micro Incision Cataract Surgery (MICS) for cataract treatment. The hospital provides specialized services across multiple ophthalmology subspecialties including cornea and ocular surface treatment, glaucoma management, retinal disease and diabetic eye care, pediatric ophthalmology with squint surgery, binocular vision therapy, orbit and oculoplasty, and uveitis treatment. Supporting services include eye bank for corneal transplants, charitable Lotus Vision Research Trust for outreach programs, optical retail, and pharmacy. Academic programs encompass B.Sc. Optometry (Alagappa University partnership), DNB residency, and multiple clinical fellowships in cornea/refractive surgery, vitreo-retinal surgery, and glaucoma. The hospital integrates with insurance providers and TPAs for patient billing and accepts various government health schemes.

Differentiator

Problem solved

Functional benefit

Products and services

• SMILE PRO Advanced AI-enabled refractive surgery using ZEISS VISUMAX 800 technology for vision correction with 9-second laser treatment, flap-free minimally invasive approach, and AI precision for ultra-accurate results in myopia and astigmatism treatment.
• ReLEx SMILE Flapless, painless, bladeless femtosecond laser eye surgery using Carl Zeiss VisuMax technology for myopia (-0.5D to -10D) and astigmatism (up to -5D) correction, performed in 15 minutes with 2-4mm incision.
• Touchfree Laser (SCHWIND AMARIS 750S) Touch-free laser eye surgery using SCHWIND AMARIS 750S excimer laser with 6D eye tracking, 750 pulses per second, treating myopia, hyperopia, astigmatism, and presbyopia with 0.54mm diameter laser beam.
• LASIK Eye Surgery Traditional laser-assisted in-situ keratomileusis procedure reshaping cornea with excimer laser for correction of nearsightedness, farsightedness, astigmatism, and higher-order aberrations. Includes Standard LASIK, Zyoptix LASIK, and Zyoptix Ultimate variants. Starting from Rs. 9,999 per eye.
• Epi-LASIK Epithelial Laser In Situ Keratomileusis procedure for thin cornea and high myopia patients (up to -20D), introduced first in Southeast Asia in 2004, overcoming LASIK limitations.
• Intralase 100% blade-free technique using femtosecond laser to create corneal flap for LASIK procedure, providing smoother bed surface and precise flap positioning compared to mechanical microkeratome.
• Zyoptix Supracor German Technolas technology LASIK procedure for presbyopia correction in 40+ age group, treating near, intermediate, and distance vision in under 20 seconds while maintaining natural eye shape.
• Zyoptix Ultimate Premium LASIK treatment using Technolas 217P platform with iris recognition technology and active multi-dimensional eye tracker for precise correction of existing and post-LASIK aberrations.
• Robotic Femto Laser Cataract Surgery (LRCS) Laser-assisted cataract surgery using femtosecond laser guided by OCT imaging for precise incisions, computer-guided accuracy, and IOL implantation, safer and more reliable than traditional blade cataract surgery.
• Phacoemulsification Ultrasound-based cataract removal technique using 2mm incisions to emulsify cloudy lens and replace with foldable intraocular lens (IOL), offering fast outpatient procedure with excellent vision outcomes.
• Micro Incision Cataract Surgery (MICS) Minimally invasive cataract surgery performed through incisions less than 1.8mm, using reduced phaco energy for safer healing and faster recovery compared to standard phacoemulsification.
• Paediatric Eye Care and Squint Surgery Specialized eye care for children including refractive error correction, squint treatment, amblyopia therapy, ROP screening, low vision aids, and vision therapy exercises.
• Cataract Surgery Complete cataract treatment including diagnosis, surgery (femtosecond laser, phaco, MICS options), and IOL implantation (monofocal, multifocal, toric, accommodating lenses) for permanent vision restoration.
• Cornea and Ocular Surface Treatment Comprehensive cornea care including infectious disease treatment, keratoconus management (C3R, INTACS), corneal transplants (DALK, DSEK, DMEK), and ocular surface disorder treatment.
• Glaucoma Treatment Medical, laser (YAG iridotomy), and surgical (trabeculectomy, valve implantation) treatments for glaucoma with comprehensive diagnostic services including visual field testing and OCT imaging.

Quantifiable outcome

• 98% of patients achieve near-perfect vision after SCHWIND AMARIS treatment
• +5 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• SCHWIND (Germany)coreTechnology or Integration · 15 December 2019SCHWIND provides AMARIS 750S excimer laser technology for touch-free laser eye surgery. Inaugurated by Telangana Governor Dr. Tamilisai Soundararajan. Features 6D eye tracking and 750 pulses per second for rapid, precise ablation.
• Carl Zeiss AG, GermanycoreTechnology or IntegrationZEISS supplies VisuMax femtosecond laser technology for ReLEx SMILE and SMILE PRO procedures. The VisuMax laser provides micrometer-precision refractive correction with bladeless, flapless laser vision correction capability.
• Technolas (Germany)coreTechnology or IntegrationTechnolas provides Zyoptix 217P platform with Zyoptix Ultimate and Zyoptix Supracor treatments. Features Iris recognition technology and active multi-dimensional eye tracker for personalized vision correction.
• Alcon (LenSx)coreTechnology or IntegrationLenSx Femtosecond Laser used for Robotic Femto Laser Cataract Surgery (LRCS) at RS Puram center. Computer-guided incisions for safer, more reliable cataract surgery.
• Alagappa UniversitycoreStrategic or Co-development PartnerAcademic partnership where B.Sc. Optometry program is registered with Alagappa University. Curriculum designed jointly with 3-year academic period plus 1-year internship across 7 hospital branches.
• National Board of Examinations (NBE)coreStrategic or Co-development PartnerDNB (Diplomate of National Board) ophthalmology program conducted under NBE guidelines. 10 seats (5 Primary + 5 Post DO) with annual appraisal conducted by NBE.
• United India Insurance Company LimitedcoreChannel Partner/ Reseller/ DistributorPrimary insurance partner for government health schemes including CM Scheme (Chief Minister Health Insurance), PMJAY, Tamil Nadu state government employees and pensioners schemes, and co-operative employees scheme.
• 20+ Third Party Administrators (TPAs)coreChannel Partner/ Reseller/ DistributorNetwork of TPAs including Medi Assist, Vidal Healthcare, Paramount Health Services, Raksha TPA, and others for cashless treatment facilities. Enables insurance-covered patient access.
• 20+ Insurance CompaniescoreChannel Partner/ Reseller/ DistributorPartnerships with insurance companies including Apollo Munich, HDFC ERGO, ICICI Lombard, Star Health, Tata AIG, and others for direct billing and cashless services.
• Eye Bank Association of IndiaminorStrategic or Co-development PartnerLotus Eye Bank is affiliated with Eye Bank Association of India for corneal tissue procurement, quality standards, and distribution for corneal transplants.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Centre for Sight: Large national eye care chain with 80+ centers across India providing LASIK, cataract, glaucoma, and pediatric ophthalmology. Direct competitor in advanced refractive and cataract surgery segments.
• Eye-Q Vision: Indian eye hospital chain offering LASIK, cataract, and specialty eye care across multiple cities. Provides similar super specialty services at competitive price points relevant to volume segments.
• Sankara Nethralaya: Chennai-based pioneering eye hospital and research institution with strong ophthalmology training programs. Comparable specialty eye care depth, academic mission, and Tamil Nadu/regional overlap.
• ASG Eye Hospital: Multi-location Indian eye hospital chain offering comprehensive ophthalmology including advanced cataract, refractive surgery, and retinal care. Competes in North and East India with growing South India footprint.
• Narayana Nethralaya: Bangalore-based specialty eye hospital under Narayana Health group offering advanced ophthalmology services. Comparable in specialty depth, academic programs, and South India geographic focus.
• Dr. Agarwal's Eye Hospital: India's largest listed/private eye hospital chain with 150+ centers across India and Africa. Offers comprehensive ophthalmology (LASIK, cataract, retina, glaucoma) at similar price points and competes head-on with Lotus in Tamil Nadu and Kerala markets.
• Vasan Eye Care (Vasan Healthcare): Previously India's largest eye hospital chain with strong South India presence. Now under restructuring. Direct historical competitor with overlapping Tamil Nadu/Kerala footprint and similar service portfolio.
• Maxivision Super Specialty Eye Hospitals: South India-based eye hospital chain with super specialty services including refractive surgery, cataract, and retina. Directly competes with Lotus in Tamil Nadu, Kerala, and Andhra Pradesh with similar multi-center model.

Broad incumbents

• Apollo Hospitals: India's largest multi-specialty hospital chain with ophthalmology departments. Differs in its broad multi-specialty model versus Lotus's specialty eye hospital focus, but overlaps for premium cataract and refractive patients.
• Medanta - The Medicity: Large multi-specialty hospital group with ophthalmology departments. Competes for premium eye care patients but lacks Lotus's specialty-only focus and South India depth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCG3oaBaW7GrzMp0TB1qf2sQ
• Facebookfacebook.com/lotuseyehospitalandinstitute
• Instagraminstagram.com/lotus_eyehospital/?hl=en
• Xx.com/Lotuseyehosp
• LinkedInlinkedin.com/company/3857560

Revenue estimate

Valuation estimate

Number of profiles

Profiles32 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lotus Eye Hospital and Institute